779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors

779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors

Bibliographic Details
Main Authors: Aung Naing, Emiliano Calvo, Chen Zhu, Martin Gutierrez, Elena Garralda, Giovanni Abbadessa, Helene Guillemin-Paveau, Meijing Wu, Raymond Perez, Marloes van Dongen, Ferry Eskens, Morgan Finlay, Fatima Menas, Ozlem Yildirim
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items